Monitoring of minimal residual disease in NPM1 mutated acute myeloid leukemia (AML) – a single center experience in 27 patients.

Authors

DVOŘÁKOVÁ Dana RÁČIL Zdeněk PALÁSEK Ivo PROTIVÁNKOVÁ Markéta JEŽÍŠKOVÁ Ivana LENGEROVÁ Martina MAYER Jiří

Year of publication 2009
Type Article in Periodical
Magazine / Source Blood
MU Faculty or unit

Faculty of Medicine

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info

By clicking “Accept Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Settings

Necessary Only Accept Cookies